| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.3M | — | +51.7% |
| Cost of Revenue | $1.6M | — | +4.8% |
| R&D Expense | $1.2M | — | -15.5% |
| SG&A Expense | $5.4M | — | -11.8% |
| Operating Income | -$12.1M | — | +3.0% |
| Pre-tax Income | -$13.9M | — | +48.3% |
| Income Tax | $0 | — | — |
| Net Income | -$13.9M | — | +48.3% |
| EPS (Basic) | -$0.17 | — | +67.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $689K | +7.2% | +1029.5% |
| Inventory | $469K | +32.9% | -3.1% |
| Current Assets | $31.4M | -16.3% | +13.9% |
| Total Assets | $34.1M | -15.7% | +3.9% |
| Current Liabilities | $29.4M | +2.8% | -19.6% |
| Total Liabilities | $30.1M | +1.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.1M | — | +2.9% |
| Capital Expenditures | $215K | — | +131.2% |
| Investing Cash Flow | -$215K | — | -131.2% |
| Financing Cash Flow | $5.5M | — | -64.5% |
| Free Cash Flow | -$12.3M | — | +1.9% |
| -21.2% |
| Stockholders' Equity | $4.0M | -63.4% | +174.4% |